Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Chen

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Transplantation|August 21, 2025
MHC Class II Sharing Appears to Promote Intestinal Allograft Tolerance Through Linked Suppression in a Large Animal ModelM Esad Gunes, Satyajit Patwardhan, Sarah Merl, et al.
Nature Structural & Molecular Biology|February 5, 2024
A novel class of inhibitors that disrupts the stability of integrin heterodimers identified by CRISPR-tiling-instructed genetic screensNicole M Mattson, Anthony K N Chan, Kazuya Miyashita, et al.
Science Advances|February 23, 2024
Therapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug DiscoveryAnthony K N Chan, Li Han, Christopher D Delaney, et al.
Molecular Cell|May 22, 2025
A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline gliomaEimear Lagan, Dáire Gannon, Ademar Jesus Silva, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Transplantation|August 21, 2025
MHC Class II Sharing Appears to Promote Intestinal Allograft Tolerance Through Linked Suppression in a Large Animal ModelM Esad Gunes, Satyajit Patwardhan, Sarah Merl, et al.
Nature Structural & Molecular Biology|February 5, 2024
A novel class of inhibitors that disrupts the stability of integrin heterodimers identified by CRISPR-tiling-instructed genetic screensNicole M Mattson, Anthony K N Chan, Kazuya Miyashita, et al.
Science Advances|February 23, 2024
Therapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug DiscoveryAnthony K N Chan, Li Han, Christopher D Delaney, et al.
Molecular Cell|May 22, 2025
A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline gliomaEimear Lagan, Dáire Gannon, Ademar Jesus Silva, et al.
Pageof 4